LTRPA yields 763.36% · PFE yields 6.13%● Live data
📍 LTRPA pulled ahead of the other in Year 1
Combined, LTRPA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LTRPA + PFE for your $10,000?
Liberty TripAdvisor Holdings, Inc., through its subsidiaries, operates travel guidance platform that connects travelers with travel partners. The company operates through two segments, Hotels, Media & Platform, and Experiences & Dining. Its travel platform provides content, price comparison tools, and online reservation and related services for destinations, accommodations, travel activities and experiences, and restaurants. The company owns and operates a portfolio of online travel guidance brands and businesses, which offers travel-planning and trip-taking resources in the travel industry; and provides click-based, display-based, and subscription-based advertising services. It also operates Viator, a website that offers research, book, and experience activities and attractions in travel destinations; and TheFork, an online restaurant reservations platform. The company was incorporated in 2013 and is headquartered in Englewood, Colorado.
Full LTRPA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.